Ubs Oconnor LLC Penumbra Inc Transaction History

Ubs Oconnor LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$172.27 - $223.95 $51,681 - $67,185	-300 Reduced 5.17%	5,498 $989,000
Q1 2024 May 15, 2024	BUY	$220.09 - $273.15 $33,013 - $40,972	150 Added 2.66%	5,798 $1.29 Million
Q4 2023 Feb 14, 2024	BUY	$181.44 - $260.22 $776,381 - $1.11 Million	4,279 Added 312.56%	5,648 $1.42 Million
Q2 2023 Aug 14, 2023	BUY	$271.54 - $344.06 $371,738 - $471,018	1,369 New	1,369 $471 Million
Q1 2023 May 15, 2023	SELL	$220.43 - $278.69 $1.79 Million - $2.27 Million	-8,134 Reduced 76.91%	2,442 $680,000
Q4 2022 Feb 14, 2023	BUY	$151.88 - $228.5 $253,487 - $381,366	1,669 Added 18.74%	10,576 $0
Q3 2022 Nov 14, 2022	BUY	$120.36 - $205.88 $349,044 - $597,052	2,900 Added 48.28%	8,907 $1.69 Billion
Q2 2022 Aug 12, 2022	BUY	$116.09 - $227.33 $401,555 - $786,334	3,459 Added 135.75%	6,007 $747,000
Q1 2022 May 16, 2022	BUY	$187.51 - $283.98 $477,775 - $723,581	2,548 New	2,548 $565,000

374

29.2M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.25B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.